Some patients report reduced discomfort when injecting into areas with more subcutaneous fat, such as the abdomen, compared to leaner areas like the thigh
Canada witnessed notable market growth as its public healthcare systems offer GLP-1 coverage through provincial drug programs, strong clinical adoption through the guidelines set by endocrinologists, and the growth of private insurance that has made access to these medicines possible for weight management
The FDA prescribing information does not list generalized skin sensitivity as a recognized adverse reaction, though injection site reactions are well-documented for the subcutaneous formulations (Ozempic and Wegovy)
Interest in TCA chemical peels for acne has grown substantially year over year, driven largely by patients researching more aggressive scar treatment options
But a proper understanding of the reasons for and nature of any symptoms that arise can do much to allay the bewilderment and fear associated with benzodiazepine withdrawal and can also help prevent long-term sequelae